Crypto News1 MIN READ
CRYPTONEUTRAL
L&C Bio's Human Fat Injection May Address 'Ozempic Face'
FG
FOMOGRAM Editorial Desk
Aug 6, 2026
EXECUTIVE SUMMARY
L&C Bio's shares rise 12% following plans for a human fat-derived solution to Ozempic, supported by patents in three markets.
L&C Bio's shares rise 12% following plans for a human fat-derived solution to Ozempic, supported by patents in three markets.
FOMOGRAM SENTINEL GRAVITY TELEMETRY
General news unrelated to monitored cryptocurrencies.
BTC OVERALL MARKET INDEX: 53 / 100 (NEUTRAL)
Explore all verified news, research, and global sources for CRYPTO.